| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEAP THERAPEUTICS, INC. | Chief Medical Officer | Common Stock | 27,500 | $77,550 | $2.82 | 28 Mar 2025 | Direct |
| LEAP THERAPEUTICS, INC. | Chief Medical Officer | Restricted Stock Units | 0 | $0 | $2.82 | 28 Mar 2025 | Direct |
| Compass Therapeutics, Inc. | Chief Medical Officer | STOCK OPTION (RIGHT TO BUY) | 1,000,000 | 02 Jan 2026 | Direct | ||
| LEAP THERAPEUTICS, INC. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 85,000 | 02 Oct 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Chief Medical Officer | 05 Jan 2026, 16:33 |
| CMPX | Compass Therapeutics, Inc. | 02 Jan 2026 | 0 | $0 | 3 | Chief Medical Officer | 05 Jan 2026, 16:31 |
| LPTX | LEAP THERAPEUTICS, INC. | 28 Mar 2025 | 2 | $0 | 4 | Chief Medical Officer | 01 Apr 2025, 21:51 |
| LPTX | LEAP THERAPEUTICS, INC. | 02 Oct 2024 | 1 | $0 | 4 | Chief Medical Officer | 04 Oct 2024, 17:29 |
| LPTX | LEAP THERAPEUTICS, INC. | 29 Jan 2024 | 1 | $0 | 4 | Chief Medical Officer | 31 Jan 2024, 21:34 |
| LPTX | LEAP THERAPEUTICS, INC. | 26 Jan 2024 | 2 | $0 | 4 | Chief Medical Officer | 30 Jan 2024, 20:39 |
| LPTX | LEAP THERAPEUTICS, INC. | 23 Aug 2023 | 1 | $0 | 4 | Chief Medical Officer | 25 Aug 2023, 16:30 |
| LPTX | LEAP THERAPEUTICS, INC. | 31 Mar 2023 | 1 | $0 | 4 | Chief Medical Officer | 04 Apr 2023, 20:17 |
| LPTX | LEAP THERAPEUTICS, INC. | 01 Sep 2022 | 1 | $0 | 4 | Chief Medical Officer | 02 Sep 2022, 21:27 |
| LPTX | LEAP THERAPEUTICS, INC. | 31 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer, 10%+ Owner | 02 Feb 2022, 20:50 |
| LPTX | LEAP THERAPEUTICS, INC. | 26 May 2021 | 1 | $0 | 4 | Chief Medical Officer | 28 May 2021, 20:35 |